The Nanotechnology in Medical Devices Market in the Asia Pacific is believed to be a USD 1381.75 Million market in 2021. It is anticipated to reach USD 2672.13 Million by the end of 2026, with a tremendous CAGR of 14.1% in the forecasted period.
Nanotechnology in the medical devices deals with the repair at the cellular level having dimensions that are minute fractions of human hair. Many applications of nanotechnology are in the pipeline undergoing testing at various stages, offering exciting opportunities. Nanotechnology is in its way of revolutionizing treatment, having the potential to save many lives in the future.
The nanotechnology-based medical devices market is driven by a host of factors that include increasing funding from government and rising facilities in research and development of nanotechnology, growing the aging population's prevalence, raising awareness among the people, and growing healthcare expenditure the rising availability of insurance coverage and reimbursement.
The significant growth of the market since the last decade is attributed to the technology evolution, increasing the aging population and incidences of diseases. The nanotechnology in medicine is trusted to significantly impact the treatment, diagnosis, and prevention of diseases.
Asia Pacific has excellent facilities for R & D to invest in nanotechnology and continuously thrives for the healthcare sector's innovations, which is estimated to favor the market growth during the forecast period. Large-scale advancements in the healthcare infrastructure among countries like Taiwan, China, and India bolster the market. The growing death rate and access to modern and advanced therapeutics among patients are to surge the growth. The nanotechnology's active implantable devices in medical devices are expected to have the highest share due to hearing disorders, heart-related illness, well-established distribution channels, and the therapeutic segment hold the maximum share because of the massive number of devices and drugs come into existence in driving the market. The carelessness of daily exercise, consumption of junk foods, and growing stress levels are mounting the market growth.
However, the market also faces a few restraints that affect the growth, including stringent regulatory policies and high costs involving nanotechnology in medical devices.
This research report on the APAC Nanotechnology in Medical Devices Market has been segmented and sub-segmented into the following categories:
Regionally, The Asia-Pacific market is the fastest-growing market for nanotechnology-based medical devices, mainly due to increased population, increased international research partnerships, and increased R&D spending on nanotechnology. Moreover, significant improvements in countries such as China, Taiwan, and India's healthcare infrastructure are further driving the market in all of these regions. China is leading the APAC market in terms of volume.
Next in the lead is Japan, followed by India. Japan and India are expected to grow significantly over the forecast period due to increased career acceptance of sport and increased awareness of injuries. A growing aging population and a rising prevalence of cardiovascular diseases and diseases correlated with ribs, ears, and other organs will create opportunities for the market in these developing nations. Besides, the high costs and time-consuming product approval processes for medical devices centered on nanotechnology hinder market growth.
Companies playing an active role in the APAC Nanotechnology in Medical Devices Market are AMAG pharmaceuticals, Jude Medical, Inc., Smith & Nephew, Inc., PerkinElmer, Inc., Acusphere, Inc., 3M Company, Affymetrix, Inc., Starkey Hearing Technologies, and Stryker Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
